Skip to content

In vivo and in vitro sensitivity measurements of the circadian system. Investigating individual differences.

In vivo and in vitro sensitivity measurements of the circadian system. Investigating individual differences. - Sensitivity of the circadian system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34957
Enrollment
18
Registered
2010-04-13
Start date
2010-06-19
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

circadiane ritme stoornissen (slaapstoornissen), ploegendienst circadian rhythm disorder shift work syndrome

Interventions

None listed

Sponsors

Rijksuniversiteit Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy males between 20 and 30 years and of average chronotype

Exclusion criteria

Exclusion criteria: Symptoms of possible sleep disorder, time zone transmeridian flights (or more) one month prior to taking part in the study, Shift work during the last 3 months, Colour blindness, Visually impaired, Somatic and psychiatric diseases (no indications of depressed mood), History of chronic diseases, Excessive daily amount of caffeinated drinks, Alcohol and drug problems, Regular medication during past 3 months, Smokers, Females.

Design outcomes

Primary

MeasureTime frame
The effects of full spectrum and blue reduced light during a simulated night shift will be investigated for: the degree of melatonin suppression, skin temperature, self ratings of sleepiness, alertness, and performance. A dim light control will be used. The results on melatonin suppression will be compared within each individual for the degree of phase shift in fibroblast peripheral oscillators.

Secondary

MeasureTime frame
Prior light history will be analysed as a covariable to explain individual differences in response to light at night.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)